Redx Pharma
New data draws attention to promising fibrosis assetsRedx Pharma
All the ingredients for success now in placeRedx Pharma
Jazz Pharmaceuticals $5m milestone triggeredRedx Pharma
£34.3m raise extends runway through key data pointsRedx Pharma
RXC008 nominated as GI-ROCK drug candidateRedx Pharma
Building on an impressive track-recordRedx Pharma
FY21 results: a year of continuing deliveryRedx Pharma
R&D update: RXC004 and RXC007 in the spotlightRedx Pharma
ESMO 2021: RXC004 monotherapy Phase I study resultsRedx Pharma
Kadmon acquisition has read across for RXC007